The Present and Future of Infectious Disease Management


How should community pharmacists respond to patients presenting with or asking about potentially infectious maladies? Which preventive solutions should they recommend? The role of community pharmacists in diagnosing and treating common diseases will become more substantial with time. For example, a recent regulation in Idaho gives pharmacists prescriptive authority for certain drugs, drug categories, and devices—many of which relate to infectious diseases. In the session, presenters will provide a regulatory and business case for this expansion of services as well as advice regarding implementation, which could help other states enact similar legislation.

Pharmacist Learning Objectives

At the completion of this knowledge-based activity, participants will be able to:

  1. Propose best practices for community pharmacist management of infectious diseases.
  2. Assess the potential benefits and risks of community pharmacist management of infectious diseases in the outpatient setting.
  3. Summarize safety and efficacy data from community pharmacy–based infectious diseases management programs.
  4. Design a business model to support community pharmacist management of infectious diseases and identify potential payment for services.
Donald Klepser, PhD, MBA
Associate Professor
University of Nebraska Medical Center
Learning Level: Level 2
Pathway: Provider Status
Track: Community-Based Pharmacy Practice, Health-System Pharmacy
Session Time Slot(s): 
Monday, March 25
7:30 AM - 8:30 AM
Washington State Convention Center - Ballroom 6A
ACPE Pharmacist: 0202-0000-19-080-L04-P
CEUs Pharmacist: .1
Activity Type: